Pharmaceutical Technology on MSN
Aktis Oncology kicks 2026 IPO cycle off with $210m target
According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...
Land is often seen as the safest and most rewarding form of real estate. But in practice, most disappointments in property ...
Harbor International Fund reports 4.71% quarterly return as rate hikes impact global firms. Discover how capital cycle shifts ...
After years of being one of the most volatile entities in semiconductors, Micron is poised to enter 2026 at a significant ...
Venezuela’s oil reserves could shift global supply, ease inflation and influence U.S. interest rates, energy security and ...
Apple (NASDAQ:AAPL) shares edged higher on Wednesday after Evercore ISI highlighted the company as a top pick in technology ...
Australia’s beef and wheat exports are world class but our stock exchange is a ghost town for agriculture. Could the giants ...
How do crypto bubbles differ from traditional financial bubbles? Learn how market structure, investor psychology, and speed ...
Dante Oliveira, the 25-year-old racer from Northern California, is a multiple-time AMA champion, with two titles earned just ...
Active management is based on the belief that skilled managers can generate alpha through market insight and tactical ...
As the calendar flips from 2025 to 2026 and we welcome in the New Year, we've essentially reached the midway point in the ...
John Hancock Preferred Income Fund III offers a 9.08% yield via preferreds and corporate bonds. Click for a close look at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results